https://www.aprovix.com/mission-2 daily 0.75 2024-10-23 https://images.squarespace-cdn.com/content/v1/5cac5dcf9d41495d910ece25/1554986153277-9IGFUZMQKG1EJAO486DM/cai412-28709.jpg Mission https://images.squarespace-cdn.com/content/v1/5cac5dcf9d41495d910ece25/1554986023086-6OPDS94MJTX3UVD3Q4AA/Hand_pinne_vit_wide.jpg Mission - THE SOLUTION: QVINTIP® Qvintip® is an at-home, easy-to-use, self-test solution for HPV detection with the same accuracy as sampling performed at a clinic. With the device, women collect a vaginal fluid sample and the detachable tip is then removed and sent to a laboratory for analysis. Qvintip’s® self-sampling kit has been deemed, by women in clinical studies, to be the most comfortable and easy-to-use self-sampling device on the market. https://www.aprovix.com/home daily 0.75 2024-10-23 https://images.squarespace-cdn.com/content/v1/5cac5dcf9d41495d910ece25/1554818560223-31YDF0YXVJ1PCKP2ZD3H/pinne-axel.jpg Home https://images.squarespace-cdn.com/content/v1/5cac5dcf9d41495d910ece25/1558448756141-MBYKWD6S4J19MEB0ULT1/FAD077000832.jpg Home - HPV and Self-Sampling HPV is the primary cause of cervical cancer. Fortunately, cervical cancer is preventable with frequent HPV testing and early treatment. Self-sampling at home offer women HPV testing on their own terms. Convenience, integrity and privacy define the new way of keeping track on one’s own female health. https://images.squarespace-cdn.com/content/v1/5cac5dcf9d41495d910ece25/1566977697269-4KKVF48GLWOH6BD21I56/Website+Steps+1234.jpg Home https://www.aprovix.com/cover-language-page daily 1.0 2019-12-16 https://www.aprovix.com/team daily 0.75 2023-05-01 https://www.aprovix.com/public-sector daily 0.75 2024-10-23 https://images.squarespace-cdn.com/content/v1/5cac5dcf9d41495d910ece25/1566133468427-EF23NUK74W4KZUEVTGU6/qvintip-kit_DSC0033.jpg Public sector - Qvintip® Self-sampling for HPV analysis Qvintip® has been designed and developed for self-sampling and has initially been evaluated in collaboration with the Cytological Laboratory, Uppsala University Hospital, Sweden. Studies show that Qvintip® can: Increase participation in screening programs (Sanner et al, British Journal of Cancer 2009:101:871-874, Stenval et al, Actaderm Venereol 2007:87:243-245) Increase specificity of screening women 30-64 years old (Gyllensten et al, British Journal of Cancer 2011:105(5):694-7) Improve detection of CIN2-3 lesions compared to cytology (Wikström et al, British Journal of Cancer 2011:105(3):337-9) https://images.squarespace-cdn.com/content/v1/5cac5dcf9d41495d910ece25/1564484752166-6E3QSNL9Y7NYBBNZ905J/image-asset.jpeg Public sector https://www.aprovix.com/gynacolo daily 0.75 2025-05-22 https://images.squarespace-cdn.com/content/v1/5cac5dcf9d41495d910ece25/1555060136073-UZB12OJHCUORUW54AM3O/qvintip-kit_DSC0033.jpg Lab/Private health care provider - OFFER SELF-SAMPLING FOR HPV TO YOUR PATIENTS Offer your patients easy-to-use and reliable self-sampling for HPV test, either in the comfort of their own home or at the clinic. We can provide DNA-analysis for high-risk HPV on the samples in our accredited lab in Sweden (EES countries only). https://images.squarespace-cdn.com/content/v1/5cac5dcf9d41495d910ece25/1564484707239-STLWG4S1V01AR5Y51921/image-asset.jpeg Lab/Private health care provider https://www.aprovix.com/faq daily 0.75 2022-04-20 https://www.aprovix.com/contact-us daily 0.75 2023-03-02 https://www.aprovix.com/press daily 0.75 2024-10-23 https://www.aprovix.com/new-page-1 daily 0.75 2019-11-28 https://www.aprovix.com/new-page-2 daily 0.75 2019-11-28 https://www.aprovix.com/instructions daily 0.75 2024-10-23